Literature DB >> 29234216

Recommendations From the 2016 Guidelines for the Management of Adults With Hospital-Acquired or Ventilator-Associated Pneumonia.

Samir T Kumar, Arsheena Yassin, Tanaya Bhowmick, Deepali Dixit.   

Abstract

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) continue to represent the most common nosocomial-associated infections, resulting in significant attributable mortality, increased length of hospital stay, and financial burden.1 The updated Infectious Diseases Society of America (IDSA) guidelines provide guidance on the diagnosis and management of nonimmunocompromised hosts with HAP and VAP.

Entities:  

Year:  2017        PMID： 29234216      PMCID： PMC5720490     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  16 in total

1.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

2.  Duration of antibiotic therapy for ventilator-associated pneumonia caused by non-fermentative gram-negative bacilli.

Authors:  Traci L Hedrick; Shannon T McElearney; Robert L Smith; Heather L Evans; Timothy L Pruett; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2007-12       Impact factor: 2.150

Review 3.  Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials.

Authors:  Mary-Anne W Aarts; Jennifer N Hancock; Daren Heyland; Robin S McLeod; John C Marshall
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 4.  Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia.

Authors:  Juan F Fernandez; Stephanie M Levine; Marcos I Restrepo
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

5.  Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia.

Authors:  F Alvarez Lerma
Journal:  J Chemother       Date:  2001-02       Impact factor: 1.714

Review 6.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Authors:  Philipp Schuetz; Beat Müller; Mirjam Christ-Crain; Daiana Stolz; Michael Tamm; Lila Bouadma; Charles E Luyt; Michel Wolff; Jean Chastre; Florence Tubach; Kristina B Kristoffersen; Olaf Burkhardt; Tobias Welte; Stefan Schroeder; Vandack Nobre; Long Wei; Neera Bhatnagar; Heiner C Bucher; Matthias Briel
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

7.  Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia.

Authors:  Daren K Heyland; Peter Dodek; John Muscedere; Andrew Day; Deborah Cook
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

Review 8.  Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis.

Authors:  James D Chalmers; Catriona Rother; Waleed Salih; Santiago Ewig
Journal:  Clin Infect Dis       Date:  2013-11-22       Impact factor: 9.079

9.  Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study.

Authors:  Jordi Vallés; Ignacio Martin-Loeches; Antoni Torres; Emili Diaz; Iratxe Seijas; Maria José López; Pau Garro; Carlos Castillo; Jose Garnacho-Montero; María del Mar Martin; Maria Victoria de la Torre; Pedro Olaechea; Catia Cilloniz; Jordi Almirall; Fernando García; Roberto Jiménez; Estrella Seoane; Cruz Soriano; Eduard Mesalles; Pilar Posada
Journal:  Intensive Care Med       Date:  2014-03-18       Impact factor: 17.440

Review 10.  Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.

Authors:  Richard Pugh; Chris Grant; Richard P D Cooke; Ged Dempsey
Journal:  Cochrane Database Syst Rev       Date:  2015-08-24
View more
  2 in total

1.  Imipenem Population Pharmacokinetics: Therapeutic Drug Monitoring Data Collected in Critically Ill Patients with or without Extracorporeal Membrane Oxygenation.

Authors:  Wenqian Chen; Dan Zhang; Wenwen Lian; Xiaoxue Wang; Wenwen Du; Zhu Zhang; Dongjie Guo; Xianglin Zhang; Qingyuan Zhan; Pengmei Li
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

2.  Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges.

Authors:  Ahmed E Abou Warda; Rania M Sarhan; Hussein Saeed Al-Fishawy; Ayman N Moharram; Heba F Salem
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.